CompoSecure [CMPO] vs Esab [ESAB] Detailed Stock Comparison
CompoSecure
NASDAQ
Loading...
Esab
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CompoSecure wins in 9 metrics, Esab wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | CompoSecure | Esab | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.73 | 25.72 | CompoSecure |
| Price-to-Book Ratio | -19.59 | 3.45 | CompoSecure |
| Debt-to-Equity Ratio | 0.00 | 55.25 | CompoSecure |
| PEG Ratio | -0.09 | -1.35 | Esab |
| EV/EBITDA | 38.33 | 15.45 | Esab |
| Profit Margin (TTM) | -28.15% | 9.36% | Esab |
| Operating Margin (TTM) | 17.95% | 15.44% | CompoSecure |
| EBITDA Margin (TTM) | 17.95% | 15.44% | CompoSecure |
| Return on Equity | 37.45% | 14.87% | CompoSecure |
| Return on Assets (TTM) | 11.33% | 6.74% | CompoSecure |
| Free Cash Flow (TTM) | $121.11M | $303.62M | Esab |
| Dividend Yield | N/A | 0.27% | N/A |
| 1-Year Return | 66.67% | 11.01% | CompoSecure |
| Price-to-Sales Ratio (TTM) | 7.79 | 2.61 | Esab |
| Enterprise Value | $2.08B | $8.09B | Esab |
| EV/Revenue Ratio | 7.77 | 2.95 | Esab |
| Gross Profit Margin (TTM) | N/A | 37.18% | N/A |
| Revenue per Share (TTM) | $3 | $45 | Esab |
| Earnings per Share (Diluted) | $-2.01 | $4.57 | Esab |
| Beta (Stock Volatility) | 1.00 | 1.20 | CompoSecure |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
CompoSecure vs Esab Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CompoSecure | -2.80% | -5.04% | 2.06% | 33.42% | 97.60% | 56.03% |
| Esab | 0.92% | 8.24% | 1.93% | -5.07% | 12.33% | 0.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CompoSecure | 66.67% | 358.33% | 141.76% | 141.76% | 141.76% | 141.76% |
| Esab | 11.01% | 264.04% | 137.28% | 137.28% | 137.28% | 137.28% |
News Based Sentiment: CompoSecure vs Esab
CompoSecure
News based Sentiment: MIXED
October was a pivotal month for CompoSecure, marked by the serious issue of Nasdaq delisting alongside positive analyst upgrades and a favorable industry outlook. This creates a mixed investment narrative with significant risk and potential reward, making it a crucial period for the company's future.
Esab
News based Sentiment: MIXED
October brought conflicting signals for ESAB, with a 'Sell' rating from Barchart.com countered by a 'Buy' rating from TipRanks. Insider activity, including both grants and sales of stock units, adds to the complexity, creating a mixed investment narrative.
Performance & Financial Health Analysis: CompoSecure vs Esab
| Metric | CMPO | ESAB |
|---|---|---|
| Market Information | ||
| Market Cap | $2.09B | $7.17B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 768,890 | 519,170 |
| 90 Day Avg. Volume | 989,753 | 474,380 |
| Last Close | $19.80 | $118.64 |
| 52 Week Range | $9.24 - $21.00 | $100.17 - $135.97 |
| % from 52W High | -5.71% | -12.75% |
| All-Time High | $21.00 (Sep 29, 2025) | $135.97 (Nov 04, 2024) |
| % from All-Time High | -5.71% | -12.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.00% | 0.01% |
| Quarterly Earnings Growth | -1.00% | -0.19% |
| Financial Health | ||
| Profit Margin (TTM) | -0.28% | 0.09% |
| Operating Margin (TTM) | 0.18% | 0.15% |
| Return on Equity (TTM) | 0.37% | 0.15% |
| Debt to Equity (MRQ) | 0.00 | 55.25 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.04 | $34.10 |
| Cash per Share (MRQ) | $0.05 | $4.25 |
| Operating Cash Flow (TTM) | $66.60M | $309.95M |
| Levered Free Cash Flow (TTM) | $159.49M | $197.44M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.27% |
| Last 12-Month Dividend | $0.00 | $0.32 |
Valuation & Enterprise Metrics Analysis: CompoSecure vs Esab
| Metric | CMPO | ESAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.73 | 25.72 |
| Forward P/E | 18.03 | 21.85 |
| PEG Ratio | -0.09 | -1.35 |
| Price to Sales (TTM) | 7.79 | 2.61 |
| Price to Book (MRQ) | -19.59 | 3.45 |
| Market Capitalization | ||
| Market Capitalization | $2.09B | $7.17B |
| Enterprise Value | $2.08B | $8.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.77 | 2.95 |
| Enterprise to EBITDA | 38.33 | 15.45 |
| Risk & Other Metrics | ||
| Beta | 1.00 | 1.20 |
| Book Value per Share (MRQ) | $-1.04 | $34.10 |
Financial Statements Comparison: CompoSecure vs Esab
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CMPO | ESAB |
|---|---|---|
| Revenue/Sales | $0 | $715.59M |
| Cost of Goods Sold | $0 | $449.54M |
| Gross Profit | $0 | $266.05M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-2.66M | $110.48M |
| EBITDA | $-2.64M | $129.84M |
| Pre-Tax Income | $-66.80M | $88.10M |
| Income Tax | $-1.76M | $18.28M |
| Net Income (Profit) | $-26.13M | $68.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CMPO | ESAB |
|---|---|---|
| Cash & Equivalents | $9.51M | $258.22M |
| Total Current Assets | $10.83M | $1.34B |
| Total Current Liabilities | $47.09M | $686.47M |
| Long-Term Debt | $0 | $1.12B |
| Total Shareholders Equity | $-87.31M | $2.11B |
| Retained Earnings | $-293.59M | $720.47M |
| Property, Plant & Equipment | $0 | $415.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CMPO | ESAB |
|---|---|---|
| Operating Cash Flow | $9.71M | $41.08M |
| Capital Expenditures | $0 | $-2.69M |
| Free Cash Flow | $2.62M | $28.12M |
| Debt Repayment | $0 | $-2.50M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CMPO | ESAB |
|---|---|---|
| Shares Short | 2.92M | 1.13M |
| Short Ratio | 2.52 | 2.68 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 768,890 | 519,170 |
| Average Daily Volume (90 Day) | 989,753 | 474,380 |
| Shares Outstanding | 100.46M | 60.52M |
| Float Shares | 38.20M | 56.68M |
| % Held by Insiders | 0.54% | 0.06% |
| % Held by Institutions | 0.61% | 0.97% |
Dividend Analysis & Yield Comparison: CompoSecure vs Esab
| Metric | CMPO | ESAB |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.32 |
| Last 12-Month Dividend Yield | N/A | 0.27% |
| 3-Year Avg Annual Dividend | $0.08 | $0.23 |
| 3-Year Avg Dividend Yield | 4.58% | 0.09% |
| 3-Year Total Dividends | $0.25 | $0.70 |
| Ex-Dividend Date | May 17, 2024 | Apr 04, 2025 |